drugset / Trial / NCT00862758

Request for Single Patient IND for Compassionate/Emergency Use of Tocilizumab

NCT00862758

Expanded access No longer available University of Oklahoma Hoffmann-La Roche · collab

Summary

Application for Compassionate Use of Tocilizumab in a Boy with Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) Unresponsive to All Licensed Medications.

Timeline

Start
2009-02
Primary completion
2010-10
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Tocilizumab Monoclonal antibody 8 mg/kg Intravenous